Common drugs tested to reverse MS disability
NCT ID NCT05131828
Summary
This trial tested whether a combination of two existing, safe drugs—metformin (for diabetes) and clemastine (an antihistamine)—could help repair the protective coating around nerves in people with relapsing multiple sclerosis (MS). The goal was to see if this repair process, called remyelination, could protect nerves and potentially slow or reverse disability. The 70 participants, aged 25-50, took the drug combination or a placebo for 24 weeks while continuing their standard MS treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, United Kingdom
Conditions
Explore the condition pages connected to this study.